Inside Kost Capital's 'Trojan Horse' strategy for food tech: 'There's been too much bro talk about protein'
20 Apr 2026
13:14
Kost Capital is a Copenhagen-based food tech fund with a chef, a food scientist, and a food historian on the team.
We sat down with general partner Bodil Sidén to hear why the first wave of food tech struggled, what GLP-1 drugs mean for nutrition investing, and why she's bullish on fibre.
"There's been too much bro talk about protein," she tells Impact Loop.
We sat down with general partner Bodil Sidén to hear why the first wave of food tech struggled, what GLP-1 drugs mean for nutrition investing, and why she's bullish on fibre.
"There's been too much bro talk about protein," she tells Impact Loop.